Skip to content

Study · Not a test of the peptide alone · 2018

3 results

The effect of overweight on the luteinizing hormone level after gonadorelin stimulation test in girls with idiopathic central precocious puberty.

Lee HY, Lee YJ, Ahn MB, Cho WK, Suh BK

Annals of pediatric endocrinology & metabolism31 Dec 2018Cited by 9 (Europe PMC)

PMID30599483 (opens in a new tab)PMCIDPMC6312921 (opens in a new tab)DOI10.6065/apem.2018.23.4.215 (opens in a new tab)PepBankPUB-30599483
Read at sourcePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Gonadorelin (GnRH, LHRH) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Gonadorelin (GnRH, LHRH).

  1. 01HumanNot a test of Gonadorelin (GnRH, LHRH) aloneObservational studyOther

    In Korean girls with idiopathic central precocious puberty, peak LH after a gonadorelin stimulation test was lower in overweight girls than in normoweight girls.

    In plain wordsIn girls with early puberty, overweight girls had a lower LH peak in a gonadorelin test than normal-weight girls.

    Peptide
    Gonadorelin (GnRH, LHRH)
    Outcome
    DecreasePeak LH after gonadorelin stimulation, overweight versus normoweight
    Study

    n: not reported in source

    Comparator
    Normoweight girls with idiopathic CPP
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Measurements

    Peak LH
    8.95 U/L
    overweight girls
    Peak LH
    11.97 U/L
    normoweight girls

    Source sentences

    Summary
    The peak LH (8.95±2.85 U/L vs. 11.97±8.42 U/L, P<0.01) and peak follicle-stimulating hormone (9.60±2.91 U/L vs. 11.17±7.77 U/L, P=0.04) after gonadorelin stimulation were lower in overweight girls with idiopathic CPP than in normoweight girls with idiopathic CPP.
    1 context sentence
    Summary · context
    Medical records of 234 girls diagnosed with idiopathic CPP were reviewed retrospectively.

    In this study, Gonadorelin (GnRH, LHRH) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gonadorelin (GnRH, LHRH).

  2. 02HumanNot a test of Gonadorelin (GnRH, LHRH) aloneObservational studyOther

    In Korean girls with idiopathic central precocious puberty, peak FSH after a gonadorelin stimulation test was lower in overweight girls than in normoweight girls.

    In plain wordsIn girls with early puberty, overweight girls had a lower FSH peak in a gonadorelin test than normal-weight girls.

    Peptide
    Gonadorelin (GnRH, LHRH)
    Outcome
    DecreasePeak FSH after gonadorelin stimulation, overweight versus normoweight
    Study

    n: not reported in source

    Comparator
    Normoweight girls with idiopathic CPP
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Measurements

    Peak FSH
    9.6 U/L
    overweight girls
    Peak FSH
    11.17 U/L
    normoweight girls

    Source sentences

    Summary
    The peak LH (8.95±2.85 U/L vs. 11.97±8.42 U/L, P<0.01) and peak follicle-stimulating hormone (9.60±2.91 U/L vs. 11.17±7.77 U/L, P=0.04) after gonadorelin stimulation were lower in overweight girls with idiopathic CPP than in normoweight girls with idiopathic CPP.
    1 context sentence
    Summary · context
    Medical records of 234 girls diagnosed with idiopathic CPP were reviewed retrospectively.

    In this study, Gonadorelin (GnRH, LHRH) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gonadorelin (GnRH, LHRH).

  3. 03HumanNot a test of Gonadorelin (GnRH, LHRH) aloneObservational studyOther

    In Korean girls with idiopathic central precocious puberty, being overweight was negatively associated with peak LH after a gonadorelin stimulation test.

    In plain wordsIn girls with early puberty, being overweight was linked to a lower LH peak in a gonadorelin test.

    Peptide
    Gonadorelin (GnRH, LHRH)
    Outcome
    DecreaseAssociation of overweight with peak LH
    Study

    n: not reported in source

    Comparator
    Normoweight girls with idiopathic CPP
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Measurements

    Odds ratio
    0.89 ratio
    overweight and peak LH

    Source sentences

    Summary
    Being overweight was negatively associated with peak LH levels after gonadorelin stimulation test (odds ratio, 0.89; 95 % confidence interval, 0.81-0.98, P=0.02).
    1 context sentence
    Summary · context
    Medical records of 234 girls diagnosed with idiopathic CPP were reviewed retrospectively.

    In this study, Gonadorelin (GnRH, LHRH) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gonadorelin (GnRH, LHRH).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.